Trials / Completed
CompletedNCT03088956
Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)
A Study to Model Rates of Change on Neuropsychological Test Measures in Subjects Diagnosed With Behavioral Variant Frontotemporal Dementia and Healthy Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 47 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The objectives of the study are to; (1) estimate the change in disease -related cognitive decline over 1 year on a battery of cognitive tests administered to participants with early-stage symptomatic Behavioral Variant Frontotemporal Dementia (bvFTD) phenotypic variant; (2) identify the cognitive test or brief battery of cognitive tests which are the most sensitive to detect bvFTD progression; (3) determine the optimal schedule of administration of cognitive tests to detect bvFTD progression; (4) evaluate the relationship between cognitive tests and measures of behavior, function, caregiver's burden, quality of life (QOL); and (5) obtain blood samples for genetic and exploratory biomarkers correlations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Assessments | Cognitive, Behavioral and Functional as described in the Outcome Measures |
Timeline
- Start date
- 2018-01-19
- Primary completion
- 2019-09-23
- Completion
- 2019-09-23
- First posted
- 2017-03-24
- Last updated
- 2020-06-16
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03088956. Inclusion in this directory is not an endorsement.